205 related articles for article (PubMed ID: 16828741)
1. Iron ions derived from the nitric oxide donor sodium nitroprusside inhibit mineralization.
Huitema LF; van Weeren PR; Barneveld A; van de Lest CH; Helms JB; Vaandrager AB
Eur J Pharmacol; 2006 Aug; 542(1-3):48-53. PubMed ID: 16828741
[TBL] [Abstract][Full Text] [Related]
2. The nitric oxide donor sodium nitroprusside inhibits mineralization in ATDC5 cells.
Huitema LF; Vaandrager AB; van Weeren PR; Barneveld A; Helms JB; van de Lest CH
Calcif Tissue Int; 2006 Mar; 78(3):171-7. PubMed ID: 16523220
[TBL] [Abstract][Full Text] [Related]
3. S-nitroso-N-acetylpenicillamine and nitroprusside induce apoptosis in a neuronal cell line by the production of different reactive molecules.
Terwel D; Nieland LJ; Schutte B; Reutelingsperger CP; Ramaekers FC; Steinbusch HW
Eur J Pharmacol; 2000 Jul; 400(1):19-33. PubMed ID: 10913581
[TBL] [Abstract][Full Text] [Related]
4. The iron component of sodium nitroprusside blocks NMDA-induced glutamate accumulation and intracellular Ca2+ elevation.
Oh S; McCaslin PP
Neurochem Res; 1995 Jul; 20(7):779-84. PubMed ID: 7477670
[TBL] [Abstract][Full Text] [Related]
5. Role of oxygen-derived metabolites in the rat gastric mucosal injury induced by nitric oxide donors.
Lamarque D; Whittle BJ
Eur J Pharmacol; 1995 Apr; 277(2-3):187-94. PubMed ID: 7493608
[TBL] [Abstract][Full Text] [Related]
6. Sodium nitroprusside prevents chemical hypoxia-induced cell death through iron ions stimulating the activity of the Na+-Ca2+ exchanger in C6 glioma cells.
Amoroso S; Tortiglione A; Secondo A; Catalano A; Montagnani S; Di Renzo G; Annunziato L
J Neurochem; 2000 Apr; 74(4):1505-13. PubMed ID: 10737607
[TBL] [Abstract][Full Text] [Related]
7. The formation of reactive oxygen species in a fraction of rat brain by metabolism of nitric oxide.
Bondy SC; Naderi S
Neurosci Lett; 1994 Feb; 168(1-2):34-6. PubMed ID: 8028790
[TBL] [Abstract][Full Text] [Related]
8. Iron released by sodium nitroprusside contributes to heme oxygenase-1 induction via the cAMP-protein kinase A-mitogen-activated protein kinase pathway in RAW 264.7 cells.
Kim HJ; Tsoy I; Park MK; Lee YS; Lee JH; Seo HG; Chang KC
Mol Pharmacol; 2006 May; 69(5):1633-40. PubMed ID: 16439612
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide donors or nitrite counteract copper-[dithiocarbamate](2)-mediated tumor cell death and inducible nitric oxide synthase down-regulation: possible role of a nitrosyl-copper [dithiocarbamate](2) complex.
Rhenals MV; Strasberg-Rieber M; Rieber M
J Med Chem; 2010 Feb; 53(4):1627-35. PubMed ID: 20108933
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide reduces nontransferrin-bound iron transport in HepG2 cells.
Barisani D; Cairo G; Ginelli E; Marozzi A; Conte D
Hepatology; 1999 Feb; 29(2):464-70. PubMed ID: 9918923
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide donors, sodium nitroprusside and S-nitroso-N-acetylpencillamine, stimulate myoblast proliferation in vitro.
Ulibarri JA; Mozdziak PE; Schultz E; Cook C; Best TM
In Vitro Cell Dev Biol Anim; 1999 Apr; 35(4):215-8. PubMed ID: 10478801
[TBL] [Abstract][Full Text] [Related]
12. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178.
Wang J; Fillebeen C; Chen G; Andriopoulos B; Pantopoulos K
Mol Cell Biol; 2006 Mar; 26(5):1948-54. PubMed ID: 16479012
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide induces dose-dependent CA(2+) transients and causes temporal morphological hyperpolarization in human neutrophils.
Loitto VM; Nilsson H; Sundqvist T; Magnusson KE
J Cell Physiol; 2000 Mar; 182(3):402-13. PubMed ID: 10653607
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of macrophage-dependent low density lipoprotein oxidation by nitric-oxide donors.
Hogg N; Struck A; Goss SP; Santanam N; Joseph J; Parthasarathy S; Kalyanaraman B
J Lipid Res; 1995 Aug; 36(8):1756-62. PubMed ID: 7595096
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide- and nitric oxide donors-induced relaxation and its modulation by oxidative stress in piglet pulmonary arteries.
López-López JG; Pérez-Vizcaíno F; Cogolludo AL; Ibarra M; Zaragozá-Arnáez F; Tamargo J
Br J Pharmacol; 2001 Jul; 133(5):615-24. PubMed ID: 11429384
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
17. A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats.
Serra PA; Rocchitta G; Esposito G; Delogu MR; Migheli R; Miele E; Desole MS; Miele M
Br J Pharmacol; 2001 Sep; 134(2):275-82. PubMed ID: 11564645
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of [3H]MK-801 binding by ferrous (II) but not ferric (III) ions in a manner different from that by sodium nitroprusside (II) in rat brain synaptic membranes.
Shuto M; Ogita K; Minami T; Maeda H; Yoneda Y
J Neurochem; 1997 Aug; 69(2):744-52. PubMed ID: 9231735
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of nitric oxide against iron-induced neuronal damage.
Nara K; Konno D; Uchida J; Kiuchi Y; Oguchi K
J Neural Transm (Vienna); 1999; 106(9-10):835-48. PubMed ID: 10599866
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase and apoptosis in murine proximal tubule epithelial cells.
Tiwari MM; Messer KJ; Mayeux PR
Toxicol Sci; 2006 Jun; 91(2):493-500. PubMed ID: 16551643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
